Subscribe to our Newsletters !!
Like never seen before, coral reefs across the
High capacity and performance combined with an int
With a stellar legacy spanning over five decades,
It is with utmost pride that Microbioz India annou
The world of pharmaceuticals encompasses a broad s
For some time now,
In our cover story, we shine a spotlight on “ The Magazine
Seegene Inc Seol Korea based company used newly created artificial intelligence (AI)-based assay development system to develop two multiplexed molecular diagnostics for meningitis and Sexually transmitted Diseases.
The assays are based on Allplex real-time polymerase chain reaction (PCR) reagents designed to detect eight different DNA targets simultaneously.
The Seegene digitized development system automates real-time PCR assay development, driving down the cost of molecular diagnostic tests and enabling nonprofessionals to develop multiplexed assays.
The company’s pipeline of products includes assays that diagnose not only infectious diseases but also drug-resistant pathogens, genetic disorders, and various cancers, including breast, colon, and lung cancers.
For more information
